citalopram

1
Reactions 1073 - 15 Oct 2005 S Citalopram Inappropriate antidiuretic hormone secretion in an elderly patient: case report An 81-year-old woman developed inappropriate antidiuretic hormone secretion during treatment with citalopram [therapeutic indications not clearly stated]. The woman, who had been treated with amitriptyline for 2 years, started receiving citalopram [dosage not stated] because her depressive symptoms did not improve; other concomitant medication included ramipril, bisoprolol, amlodipine and moxonidine. Two months later, she was hospitalised with a 5-day history of confusion, drowsiness, reduced food intake, vomiting and stupor. Laboratory investigations revealed a serum sodium level of 112 mmol/L (normal 135–152) and a serum osmolality of 225 mOsm/kg H2O (280–300), with inappropriately normal urine osmolality and urinary sodium. She was diagnosed with inappropriate antidiuretic hormone secretion after other cases of hyponatraemia were excluded. Amitriptyline and citalopram were discontinued. The woman received saline solution and, within 1 day, her serum sodium level was increased to 120 mmol/L. After 3 days, she was put on a fluid restriction and received sodium chloride tablets. Within the following 9 days, her serum sodium level was 136 mmol/L and her symptoms improved, but she was not fully orientated until day 15. No further antidepressant treatment was started. Author comment: "Hyponatraemia developed shortly after therapy with citalopram had been started and, therefore, was most likely related to the initiation of citalopram therapy, possibly in combination with amitriptyline. Except for amitriptyline and citalopram the patient continued treatment with her previous medications. For amlodipine and ramipril, also taken by the patient, hyponatraemia is reported as well. However, citalopram is the only drug that has been added or modified." Miehle K, et al. Citalopram therapy as a risk factor for symptomatic hyponatremia caused by the syndrome of inappropriate secretion of antidiuretic hormone (SIADH): a case report. Pharmacopsychiatry 38: 181-182, No. 4, Jul 2005 - Germany 801018466 1 Reactions 15 Oct 2005 No. 1073 0114-9954/10/1073-0001/$14.95 Adis © 2010 Springer International Publishing AG. All rights reserved

Upload: lamkhanh

Post on 16-Mar-2017

214 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Citalopram

Reactions 1073 - 15 Oct 2005

SCitalopram

Inappropriate antidiuretic hormone secretion in anelderly patient: case report

An 81-year-old woman developed inappropriate antidiuretichormone secretion during treatment with citalopram[therapeutic indications not clearly stated].

The woman, who had been treated with amitriptyline for2 years, started receiving citalopram [dosage not stated]because her depressive symptoms did not improve; otherconcomitant medication included ramipril, bisoprolol,amlodipine and moxonidine. Two months later, she washospitalised with a 5-day history of confusion, drowsiness,reduced food intake, vomiting and stupor. Laboratoryinvestigations revealed a serum sodium level of 112 mmol/L(normal 135–152) and a serum osmolality of 225 mOsm/kgH2O (280–300), with inappropriately normal urine osmolalityand urinary sodium. She was diagnosed with inappropriateantidiuretic hormone secretion after other cases ofhyponatraemia were excluded.

Amitriptyline and citalopram were discontinued. Thewoman received saline solution and, within 1 day, her serumsodium level was increased to 120 mmol/L. After 3 days, shewas put on a fluid restriction and received sodium chloridetablets. Within the following 9 days, her serum sodium levelwas 136 mmol/L and her symptoms improved, but she was notfully orientated until day 15. No further antidepressanttreatment was started.

Author comment: "Hyponatraemia developed shortly aftertherapy with citalopram had been started and, therefore, wasmost likely related to the initiation of citalopram therapy,possibly in combination with amitriptyline. Except foramitriptyline and citalopram the patient continued treatmentwith her previous medications. For amlodipine and ramipril,also taken by the patient, hyponatraemia is reported as well.However, citalopram is the only drug that has been added ormodified."Miehle K, et al. Citalopram therapy as a risk factor for symptomatic hyponatremiacaused by the syndrome of inappropriate secretion of antidiuretic hormone(SIADH): a case report. Pharmacopsychiatry 38: 181-182, No. 4, Jul 2005 -Germany 801018466

1

Reactions 15 Oct 2005 No. 10730114-9954/10/1073-0001/$14.95 Adis © 2010 Springer International Publishing AG. All rights reserved